As Lisbon played host to BIO Europe Spring, an annual conference that brings together professionals across the global biotech sector, the continent’s journey back to prime competitiveness took centre stage.
Pharmaceutical Technology attended the event, held from 23-25 March, and spoke to several leading executives and investors on this topic, as well as China’s rise to role of pharmaceutical titan and the innovative sector of gene therapies.
In this latest episode, pharmaceutical editor Robert Barrie rounds up the key trends and takeaways from interviews and panels at the conference.
Experts interviewed in the podcast include Jan Van Den Bossche, investor at Andera Partners; Philipp Schreppel, business development senior director at mRNA specialist Ethris; and Natalia Misciattell, CEO of gene therapy developer AAVantgarde BIO.
